Smith Seminars Online Respiratory Disorders in Neonates and Infants Test


Fill out all required fields (*) and press submit. Once we receive your test it will be graded and you will receive your certificate per your chosen method of delivery.

 

If for some reason you do not pass the test with 70% correct you will be notified by email to retake the test. Your order number will stay valid until you pass the test.

 

 Part 1 - Your Information

 

Name:

*

Address:

*

City:

*

State:

*

Zip:

*

Email:

*

Day Phone:

*

Fax Number:

Certificate Delivery:

*

Order Number:

*

AARC Member #:

CEBroker #:

(if applicable)

 

 Part 2 - The Test

 

1) Differences in the physiology of the respiratory system in infants compared with that of older children and adults include:

A) Less reliance on diaphragmatic excursions over intercostal muscles

B) Less collapsible extrathoracic airways

C) More compliant collapsible chest wall

D) All of the above

2) Typical apnea monitors use:

A) An elastic band to detect leg movements

B) Pulse oximetry to detect heart rate and O2 saturation

C) A & B

D) None of the above

3) Bronchopulmonary dysplasia:

A) Is typically suspected when a ventilated infant is unable to wean from O2 therapy, mechanical ventilation, or both

B) Is caused by low concentrations of inspired O2 typically in patients on prolonged mechanical ventilation

C) Incidence increases with degree of prematurity; increased airway resistance and pulmonary artery pressures, and female sex

D) All the above

4) Meconium aspiration can cause:

A) Chemical pneumonitis

B) Mechanical bronchial obstruction producing a syndrome of respiratory distress

C) Tachypnea, rales and rhonchi, and cyanosis or desaturation

D) All the above

5) Diagnosis of persistent pulmonary hypertension of the newborn includes:

A) History and examination

B) Electromylogram

C) Response to PCO2

D) None of the above

6) Pulmonary surfactant:

A) Is a mixture of phospholipids and lipoproteins secreted by type II pneumocytes
B) Diminishes the surface tension of the water film that lines alveoli
C) A & B
D) None of the above

7) Symptoms and signs of respiratory distress syndrome include:

A) Rapid, labored, grunting respirations appearing a few hours after delivery
B) Suprasternal and substernal retractions and nasal flaring
C) Cyanosis, lethargy, irregular breathing, and apnea
D) All the above

8) ECMO is a form of cardiopulmonary bypass:

A) Used for infants who cannot be adequately oxygenated or ventilated with conventional ventilators
B) Is contraindicated in infants less than 34 weeks and/or less than 2 kg
C) A & B
D) None of the above

9) Chronic health conditions:

A) Are generally defined as those conditions that last greater than 12 months
B) Are severe enough to create some limitations in usual activity
C) Affect 10 to 30% of children, depending on the criteria
D) All the above

10) A critically ill infant:

A) Who experiences skin-to-skin contact gains weight faster when compared with those who do not receive such care
B) Is never separated from their families because of hospitalization and treatment
C) Is never separated from the parents during transport to a different hospital
D) None of the above

 

 Part 3 - Evaluation

 

 Learner's achievement of each objective. Rate each on a scale of 1=low 5=high

 

Objective 1

1) List the causes of respiratory distress in neonates and infants Summarize the factors of apnea in the premature infant Identify factors of bronchopulmonary dysplasia & meconium aspiration Explain the etiology, diagnosis, pathophysiology, prognosis, and treatment of persistent pulmonary hypertension, respiratory distress syndrome, transient tachypnea, children with chronic health conditions, death and dying, and the sick neonate.

 

1   2   3   4   5  

 

Purpose/Goal of this activity:

2) Attendee will be aware of the current information and will be able to meet the required continuing education. Relationship of objectives to overall Purpose/Goal of activity.

 

1   2   3   4   5  

 

 

3) If conflict of interest, off-label use, commercial support, or in-kind support were evident in the education component of this program, were you notified? (Choose One)

 

N/A — not applicable for any of the above

Yes

No

Comments

 

 

4) Content was presented without bias of any commercial product or drug. (Choose One)

 

Yes

No

Comments

 

 

5) Will the information you gained from this program change your practice? (Choose One)

 

Yes

No

Comments

 

 

Additional comments or suggestions

 

(do not press more than once)

 


close window | print page


 

Smith Seminars

3016 W. Hwy 114 - Paradise - TX - 76073 

Toll Free - 866-857-2211 or 940-969-2288 - Fax 972-759-9791
Email
debra@smithseminars.com

site by wsc